Cited by 305Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismLipid metabolism and disorders

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112

Open access

Weisgraber, K H·1990·Journal of Lipid Research

Open this paper in CoChat — free account

Abstract

Human apolipoprotein (apo) E occurs as three common isoforms (apoE4, E3, and E2), all of which influence plasma cholesterol levels. Although both apoE4 and E3 bind with equal effectiveness to the low density lipoprotein receptor, they associate preferentially with different classes of plasma lipoproteins: apoE4 with very low density lipoproteins, apoE3 with high density lipoproteins. The primary structure of apoE3 differs from that of apoE4 at only a single site; apoE3 has its sole cysteine residue at position 112, while apoE4 contains arginine at position 112 and completely lacks cysteine. The present study investigated how this structural difference between apoE4 and E3 determines their distribution among plasma lipoproteins, and analyzed the role of the disulfide-linked heterodimer apoE-A-II (which apoE4 cannot form) in determining the distribution. Human plasma was incubated with 125I-labeled apoE, and lipoproteins were separated by agarose chromatography. Both apoE3 that had been reduced and alkylated with iodoacetamide and apoE3-A-II distributed with high density lipoproteins, indicating that a combination of an inherent property of the monomeric apoE3 structure and apoE-A-II formation account for distribution of apoE3 to the high density lipoproteins. Cysteamine modification of apoE3 resulted in an apoE4-like distribution, demonstrating that a positive charge at position 112 determined the apoE4 distribution and that the effect was not exclusively due to the presence o…

Integrity signals

Registry

Crossref · 10.1016/s0022-2275(20)42621-5

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Plasma lipoproteins: apolipoprotein structure and function.
Mahley, R. W., Innerarity, T. L., Rall, S. C., & Weisgraber, K. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34443-6 · Cited by 1,155
Self-citation
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Self-citation
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
Self-citation
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations.
Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E. A., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 403
Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345
Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.
Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., & Weisgraber, K. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68778-2 · Cited by 293
Self-citation

Show all 26 references

Research works printed but not linked: 1

Gregg, 1986, Role of cysteine residues in modulating in vivo metabolism of apoE in humans, Arteriosclerosis., 6, 566a

Sorted by citations

Items 101–200 of 305

Structure and Functions of Human Cerebrospinal Fluid Lipoproteins from Individuals of Different APOE Genotypes
Rebeck, G. W., Alonzo, N. C., Berezovska, O., Harr, S. D., Knowles, R. B., Growdon, J. H., Hyman, B. T., & Mendez, A. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6710 · Cited by 66
Molecular Mechanism of Apolipoprotein E Binding to Lipoprotein Particles
Nguyen, D., Dhanasekaran, P., Phillips, M. C., & Lund‐Katz, S. (2009) · Biochemistry · doi:10.1021/bi9000694 · Cited by 66
The small HDL particle hypothesis of Alzheimer's disease
Martinez, A. E., Weissberger, G. H., Kuklenyik, Z., He, X., Meuret, C. J., Parekh, T., Rees, J. C., Parks, B. A., Gardner, M. S., King, S. M., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12649 · Cited by 63
Cholesterol and Alzheimer's disease
Wolozin, B. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300525 · Cited by 33
Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L
Castaño, E. M., Prelli, F., Pras, M., & Frangione, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17610 · Cited by 59
Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E
Weisgraber, K. H., Pitas, R. E., & Mahley, R. W. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90212-7 · Cited by 58
Self-citation
Dissociation of Apolipoprotein E Oligomers to Monomer Is Required for High-Affinity Binding to Phospholipid Vesicles
Garai, K., Baban, B., & Frieden, C. (2011) · Biochemistry · doi:10.1021/bi1020106 · Cited by 57
ApoE and ACE genes: impact on human longevity
BOCKXMEER, F. M. V. (1994) · Nature Genetics · doi:10.1038/ng0194-4 · Cited by 56
Apolipoprotein E polymorphism, age and coronary heart disease
Kolovou, G. D., & Anagnostopoulou, K. K. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2006.11.001 · Cited by 54
Contributions of the Carboxyl-Terminal Helical Segment to the Self-Association and Lipoprotein Preferences of Human Apolipoprotein E3 and E4 Isoforms
Sakamoto, T., Tanaka, M., Vedhachalam, C., Nickel, M., Nguyen, D., Dhanasekaran, P., Phillips, M. C., Lund-Katz, S., & Saito, H. (2008) · Biochemistry · doi:10.1021/bi701923h · Cited by 54
APOE Genotype Results in Differential Effects on the Peripheral Clearance of Amyloid-β42 in APOE Knock-in and Knock-out Mice
Sharman, M. J., Morici, M., Hone, E., Berger, T., Taddei, K., Martins, I. J., Lim, W. L. F., Singh, S., Wenk, M. R., Ghiso, J., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100141 · Cited by 54
In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
Wildsmith, K. R., Basak, J. M., Patterson, B. W., Pyatkivskyy, Y., Kim, J., Yarasheski, K. E., Wang, J. X., Mawuenyega, K. G., Jiang, H., Parsadanian, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038013 · Cited by 54
Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma
Baker-Nigh, A. T., Mawuenyega, K. G., Bollinger, J. G., Ovod, V., Kasten, T., Franklin, E. E., Liao, F., Jiang, H., Holtzman, D., Cairns, N. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721779 · Cited by 54
The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
Zhang, H., Wu, J., & Zhu, J. (2010) · BioMed Research International · doi:10.1155/2010/357412 · Cited by 57
ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-I
Gaidukov, L., I, V. R., Yacobson, S., Rosenblat, M., Aviram, M., & Tawfik, D. S. (2009) · Biochemistry · doi:10.1021/bi9013227 · Cited by 54
Effects of ApoE Genotype on ApoB-48 and ApoB-100 Kinetics With Stable Isotopes in Humans
Welty, F. K., Lichtenstein, A. H., Barrett, P. H. R., Jenner, J. L., Dolnikowski, G. G., & Schaefer, E. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1807 · Cited by 51
Comparison of Lipid-Binding and Lecithin:Cholesterol Acyltransferase Activation of the Amino- and Carboxyl-Terminal Domains of Human Apolipoprotein E3
Pauw, M. D., Vanloo, B., Weisgraber, K. H., & Rosseneu, M. (1995) · Biochemistry · doi:10.1021/bi00034a030 · Cited by 50
Self-citation
Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE
Zhang, X., Yuan, T., Chen, X., Liu, X., Hu, J., & Liu, Z. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101256 · Cited by 51
Domains of apoE Required for Binding To apoE Receptor 2 and To Phospholipids: Implications For The Functions Of apoE in the Brain
Li, X., Kypreos, K. E., Zanni, E. E., & Zannis, V. I. (2003) · Biochemistry · doi:10.1021/bi027093c · Cited by 49
Bacterial overexpression, isotope enrichment, and NMR analysis of the N-terminal domain of human apolipoprotein E
Fisher, C. B., Wang, J., Francis, G. A., Sykes, B. D., Kay, C. M., & Ryan, R. O. (1997) · Biochemistry and Cell Biology · doi:10.1139/bcb-75-1-45 · Cited by 49
Conformational flexibility in the apolipoprotein E amino‐terminal domain structure determined from three new crystal forms: Implications for lipid binding
Segelke, B. W., Forstner, M., Knapp, M., Trakhanov, S. D., Parkin, S., Newhouse, Y. M., Bellamy, H. D., Weisgraber, K. H., & Rupp, B. (2000) · Protein Science · doi:10.1110/ps.9.5.886 · Cited by 47
Self-citation
Modulation of the lipid binding properties of the N‐terminal domain of human apolipoprotein E3
Weers, P. M. M., Narayanaswami, V., & Ryan, R. O. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02282.x · Cited by 47
Personalized nutrition for the prevention of cardiovascular disease: a future perspective
Lovegrove, J. A., & Gitau, R. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00889.x · Cited by 46
Apolipoprotein E structural requirements for the formation of SDS-stable complexes with β-amyloid-(1–40): the role of salt bridges
Bentley, N. M., LaDu, M. J., Rajan, C., Getz, G. S., & Reardon, C. A. (2002) · Biochemical Journal · doi:10.1042/bj20020207 · Cited by 43
Cognitive Deficits and Disruption of Neurogenesis in a Mouse Model of Apolipoprotein E4 Domain Interaction
Adeosun, S. O., Hou, X., Zheng, B., Stockmeier, C. A., Ou, X., Paul, I. A., Mosley, T. H., Weisgraber, K. H., & Wang, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497909 · Cited by 47
Self-citation
Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E
Yamauchi, K., Tozuka, M., Hidaka, H., Hidaka, E., Kondo, Y., & Katsuyama, T. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1431 · Cited by 41
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study
Blanchard, V., Ramin-Mangata, S., Billon-Crossouard, S., Aguesse, A., Durand, M., Chemello, K., Nativel, B., Flet, L., Chétiveaux, M., Jacobi, D., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p083576 · Cited by 43
Untitled work
(1993) · PubMed · Cited by 43
Effects of a Frequent Apolipoprotein E Isoform, ApoE4 Freiburg (Leu28→Pro), on Lipoproteins and the Prevalence of Coronary Artery Disease in Whites
Orth, M., Weng, W., Funke, H., Steinmetz, A., Assmann, G., Nauck, M., Dierkes, J., Ambrosch, A., Weisgraber, K. H., Mahley, R. W., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1306 · Cited by 42
Self-citation
CYP7A1-rs3808607and APOEisoform associate with LDL cholesterol lowering after plant sterol consumption in a randomized clinical trial
MacKay, D., Eck, P., Gebauer, S. K., Baer, D. J., & Jones, P. J. H. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109231 · Cited by 42
Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE
Lund-Katz, S., Wehrli, S., Zaiou, M., Newhouse, Y., Weisgraber, K. H., & Phillips, M. C. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31612-6 · Cited by 40
Self-citation
Cysteamine revisited: repair of arginine to cysteine mutations
Gallego‐Villar, L., Hannibal, L., Häberle, J., Thöny, B., Ben‐Omran, T., Nasrallah, G. K., Al-Dewik, N. I. E., Kruger, W. D., & Blom, H. J. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0060-4 · Cited by 40
Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity
Wardell, M., Rall, S., Schaefer, E., Kane, J., & Weisgraber, K. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42076-0 · Cited by 40
Self-citation
Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress
Smith, C. J., Ashford, J. W., & Perfetti, T. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181089 · Cited by 40
Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations.
Hegele, R. A., Breckenridge, W. C., Cox, D. W., Maguire, G. F., Little, J. A., & Connelly, P. W. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1303 · Cited by 39
Human Low Density Lipoprotein Receptor Fragment
Simmons, T., Newhouse, Y. M., Arnold, K. S., Innerarity, T. L., & Weisgraber, K. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25531 · Cited by 37
Self-citation
Apolipoprotein E polymorphism and plasma lipid, lipoprotein, and apolipoprotein levels in Italian children
Xu, C., Talmud, P. J., Angelico, F., Ben, M. D., Savill, J., Humphries, S. E., & Vogler, G. P. (1991) · Genetic Epidemiology · doi:10.1002/gepi.1370080605 · Cited by 39
APOE genotype modifies the association between plasma omega-3 fatty acids and plasma lipids in the Multi-Ethnic Study of Atherosclerosis (MESA)
Liang, S., Steffen, L. M., Steffen, B. T., Guan, W., Weir, N. L., Rich, S. S., Manichaikul, A. W., Vargas, J. D., & Tsai, M. Y. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.004 · Cited by 37
The presence of apoE4, not the absence of apoE3, contributes to AD pathology
Teter, B., Raber, J., Nathan, B., & Crutcher, K. A. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4305 · Cited by 37
Examination of Lipid-bound Conformation of Apolipoprotein E4 by Pyrene Excimer Fluorescence
Drury, J., & Narayanaswami, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414019200 · Cited by 37
Molecular Determinants of the Interaction Between the C‐Terminal Domain of Alzheimer's β‐Amyloid Peptide and Apolipoprotein E α‐Helices
Lins, L., Thomas‐Soumarmon, A., Pillot, T., Vandekerckhove, J. S., Rosseneu, M., & Brasseur, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730758.x · Cited by 36
Differences in the binding capacity of human apolipoprotein E3 and E4 to size‐fractionated lipid emulsions
Perugini, M. A., Schuck, P., & Howlett, G. J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03319.x · Cited by 35
Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer’s disease
Glöckner, F., Meske, V., & Ohm, T. G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00178-1 · Cited by 36
The Enhanced Association of Apolipoprotein E With Apolipoprotein B–Containing Lipoproteins in Serum-Stimulated Hepatocytes Occurs Intracellularly
Fazio, S., & Yao, Z. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.593 · Cited by 35
Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease
Yang, Y., Keene, C. D., Peskind, E. R., Galasko, D. R., Hu, S., Cudaback, E., Wilson, A. M., Li, G., Yu, C., Montine, K. S., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000207 · Cited by 35
Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability?
Weers, P. M. M., Narayanaswami, V., Choy, N., Luty, R., Hicks, L. D., Kay, C. M., & Ryan, R. O. (2002) · Biophysical Chemistry · doi:10.1016/s0301-4622(02)00300-9 · Cited by 33
Lipoprotein glomerulopathy
Tsimihodimos, V., & Elisaf, M. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328345ebb0 · Cited by 33
Cerebral lipid deposition in aged apolipoprotein-E-deficient mice.
Walker, L. C., Parker, C. A., Lipinski, W. J., Callahan, M. J., Carroll, R. T., Gandy, S., Smith, J. D., Jucker, M., & Bisgaier, C. L. (1997) · Europe PMC (PubMed Central) · Cited by 33
Evidence for differential effects of apoE3 and apoE4 on HDL metabolism
Hopkins, P. C. R., Huang, Y., McGuire, J. G., & Pitas, R. E. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200172-jlr200 · Cited by 31
Age-related macular degeneration
de Jong, E. K., Geerlings, M. J., & den Hollander, A. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816222-4.00010-1 · Cited by 32
Risk Profiles of Alzheimer Disease
Bilbul, M., & Schipper, H. M. (2011) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012129 · Cited by 34
The ApoE ε4 Isoform: Can the Risk of Diseases be Reduced by Environmental Factors?
Bos, M. M., Noordam, R., Blauw, G. J., Slagboom, P. E., Rensen, P. C. N., & van Heemst, D. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly226 · Cited by 32
N-methyl-d-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein
Sheng, Z., Prorok, M., Brown, B., & Castellino, F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.016 · Cited by 32
Untitled work
(1996) · PubMed Central · Cited by 32
Association of apolipoprotein E with α2-macroglobulin in human plasma
Krimbou, L., Tremblay, M., Davignon, J., & Cohn, J. S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33316-2 · Cited by 26
Nutrigenetics and CVD: what does the future hold?
Lovegrove, J. A., & Gitau, R. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108007040 · Cited by 30
The HepG2 Extracellular Matrix Contains Separate Heparinase- and Lipid-releasable Pools of ApoE
Burgess, J. W., Gould, D. R., & Marcel, Y. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5645 · Cited by 30
Influence of Domain Stability on the Properties of Human Apolipoprotein E3 and E4 and Mouse Apolipoprotein E
Nguyen, D., Dhanasekaran, P., Nickel, M., Mizuguchi, C., Watanabe, M., Saito, H., Phillips, M. C., & Lund-Katz, S. (2014) · Biochemistry · doi:10.1021/bi500340z · Cited by 30
Hypoxia-induced mitochondrial and nuclear DNA damage in the rat brain
Englander, E. W., Greeley, G. H., Wang, G., Perez-Polo, J. R., & Lee, H.-M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991015)58:2 · Cited by 51
Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer’s Disease
Saul, A., & Wirths, O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9674-4 · Cited by 28
Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions
Weller, R., Hueging, K., Brown, R. J. P., Tödt, D., Joecks, S., Vondran, F. W. R., & Pietschmann, T. (2017) · Journal of Virology · doi:10.1128/jvi.00422-17 · Cited by 27
Impaired secretion of apolipoprotein E2 from macrophages
Fan, D., Qiu, S., Overton, C. D., Yancey, P. G., Swift, L. L., Jerome, W. G., Linton, M. F., & Fazio, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611754200 · Cited by 27
Role of Apolipoprotein E in Alzheimer’s Disease
Zannis, V. I., Zanni, E. E., Makrides, S. C., Kardassis, D., & Aleshkov, S. B. (1998) · Springer eBooks · doi:10.1007/978-1-4899-0133-0_13 · Cited by 26
Structural changes of high‐density‐lipoprotein apolipoproteins following incubation with human polymorphonuclear cells
Cogny, A., Paul, J. L., Atger, V., Soni, T., & MOATTI, N. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18947.x · Cited by 26
Carboxyl-Terminal Domain of Human Apolipoprotein E: Expression, Purification, and Crystallization
Forstner, M., Peters-Libeu, C. A., Contreras-Forrest, E., Newhouse, Y. M., Knapp, M. S., Rupp, B., & Weisgraber, K. H. (1999) · Protein Expression and Purification · doi:10.1006/prep.1999.1144 · Cited by 26
Self-citation
Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density-lipoprotein subclass patterns
Williams, P., Dreon, D. M., & Krauss, R. M. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1234 · Cited by 26
Characterization of apolipoprotein E7 (Glu244→Lys, Glu245→Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis
Yamamura, T., Dong, L.-M., & Yamamoto, A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33364-2 · Cited by 25
Apolipoprotein E2 and E3, but Not E4, Promote Retinal Pathologic Neovascularization
Masuda, T., Shimazawa, M., Hashimoto, Y., Kojima, A., Nakamura, S., Suemori, S., Mochizuki, K., Kawakami, H., Kawase, K., & Hara, H. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20539 · Cited by 25
Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses
Lam, S. M., Huang, X., & Shui, G. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.04.011 · Cited by 25
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis
Bruschi, M., Catarsi, P., Candiano, G., Rastaldi, M. P., Musante, L., Scolari, F., Artero, M., Carraro, M., Carrea, A., Caridi, G., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00777.x · Cited by 25
Biophysical Analysis of Apolipoprotein E3 Variants Linked with Development of Type III Hyperlipoproteinemia
Georgiadou, D., Chroni, A., Vezeridis, A., Zannis, V. I., & Stratikos, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027037 · Cited by 24
In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma
Krimbou, L., Tremblay, M., Jacques, H., Davignon, J., & Cohn, J. S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32572-4 · Cited by 24
Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variant.
Fazio, S., Horie, Y., Simonet, W. S., Weisgraber, K. H., Taylor, J. M., & Rall, S. C. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41192-7 · Cited by 24
Self-citation
Preferential association of apolipoprotein E Leiden with very low density lipoproteins of human plasma.
Fazio, S., Horie, Y., Weisgraber, K., Havekes, L., & Rall, S. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40736-9 · Cited by 23
Self-citation
Linking ecological immunology and evolutionary medicine: the case for apolipoprotein E
Trotter, J. H., Liebl, A. L., Weeber, E. J., & Martin, L. B. (2010) · Functional Ecology · doi:10.1111/j.1365-2435.2010.01780.x · Cited by 22
Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E
Ray, A., Ahalawat, N., & Mondal, J. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.10.006 · Cited by 23
High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
Pedrini, S., Chatterjee, P., Hone, E., & Martins, R. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15170 · Cited by 22
Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136–>His): association with mild dyslipidemia and double pre-beta very low density lipoproteins
Minnich, A., Weisgraber, K. H., Newhouse, Y., Dong, L. M., Fortin, L. J., Tremblay, M., & Davignon, J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39754-6 · Cited by 26
Self-citation
Apolipoprotein E genotype, lifestyle and coronary artery disease: Gene-environment interaction analyses in the UK Biobank population
Bos, M. M., de Vries, L., Rensen, P. C. N., van Dijk, K. W., Blauw, G. J., van Heemst, D., & Noordam, R. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.014 · Cited by 22
Fluorescence Analysis of the Lipid Binding-Induced Conformational Change of Apolipoprotein E4
Mizuguchi, C., Hata, M., Dhanasekaran, P., Nickel, M., Phillips, M. C., Lund‐Katz, S., & Saito, H. (2012) · Biochemistry · doi:10.1021/bi300672s · Cited by 21
Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II
Shahid, S. U., Shabana, N. A., Cooper, J. A., Beaney, K. E., Li, K., Rehman, A., & Humphries, S. E. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0253-0 · Cited by 22
Apolipoprotein E5 (Glu212–>Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.
Feussner, G., Scharnagl, H., Scherbaum, C., Acar, J., Dobmeyer, J., Lohrmann, J., Wieland, H., & März, W. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39106-9 · Cited by 21
Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis
Amaro, A. B., Curco, A. S., Garcı́a, E., Julve, J., Rives, J., Benı́tez, S., & Llorente‐Cortés, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163571 · Cited by 23
Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks
Basavaraju, P., Balasubramani, R., Kathiresan, D. S., Devaraj, I., Babu, K., Vasanthakumar, A., & Moorthi, P. V. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.788852 · Cited by 22
Aberrant Hetero-Disulfide Bond Formation by the Hypertriglyceridemia-Associated p.Gly185Cys APOA5 Variant (rs2075291)
Sharma, V., Witkowski, A., Witkowska, H. E., Dykstra, A. B., Simonsen, J. B., Nelbach, L., Beckstead, J. A., Pullinger, C. R., Kane, J. P., Malloy, M. J., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304027 · Cited by 21
Analysis of high density lipoprotein apolipoproteins by capillary zone and capillary SDS gel electrophoresis
Stocks, J., Nanjee, M. N., & Miller, N. E. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34217-6 · Cited by 20
Characterization of the gene for apolipoprotein E5‐Frankfurt (Gln81 ‐> Lys, Cys112 ‐> Arg) by polymerase chain reaction, restriction isotyping, and temperature gradient gel electrophoresis
Ruzicka, V., Mäz, W., Russ, A., Fisher, E., Mondorf, W., & Groß, W. (1993) · ELECTROPHORESIS · doi:10.1002/elps.11501401164 · Cited by 21
Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E.
Raffai, R., Maurice, R., Weisgraber, K., Innerarity, T., Wang, X., MacKenzie, R., Hirama, T., Watson, D., Rassart, E., & Milne, R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41109-5 · Cited by 21
Self-citation
Effect of human apoE4 on the clearance of chylomicron-like lipid emulsions and atherogenesis in transgenic mice.
Mortimer, B., Redgrave, T. G., Spangler, E. A., Verstuyft, J. G., & Rubin, E. M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1542 · Cited by 20
Analysis of differentially expressed novel post-translational modifications of plasma apolipoprotein E in Taiwanese females with breast cancer
Uen, Y., Liao, C.-C., Lin, J.-C., Pan, Y.-H., Liu, Y., Chen, Y.-C., Chen, W.-J., Tai, C.-C., Lee, K.-W., Liu, Y., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.05.038 · Cited by 20
Characterization of transgenic mice expressing apolipoprotein E4(C112R) and apolipoprotein E4(L28P; C112R)
Huber, G., März, W., Martin, J. R., Malherbe, P., Richards, J. G., Sueoka, N., Ohm, T., & Hoffmann, M. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00341-9 · Cited by 20
Apolipoprotein E and Apolipoprotein A-1 Knock-Out Mice Readily Develop Amyloid A Protein Amyloidosis
Elliott-Bryant, R., & Cathcart, E. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4397 · Cited by 20
Current insights into apolipoprotein E and the immune response in Alzheimer's disease
Lin, P. B., & Holtzman, D. M. (2024) · Immunological Reviews · doi:10.1111/imr.13414 · Cited by 19
Human apolipoprotein E glycosylation and sialylation: from structure to function
Moon, H.-J., Luo, Y., Chugh, D., & Zhao, L. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1399965 · Cited by 18
VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation
Tetali, S. D., Budamagunta, M. S., Simion, C., den Hartigh, L. J., Kálai, T., Hideg, K., Hatters, D. M., Weisgraber, K. H., Voss, J. C., & Rutledge, J. C. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m000406 · Cited by 17
Self-citation
Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele
Gal, J., Katsumata, Y., Zhu, H., Srinivasan, S., Chen, J., Johnson, L. A., Wang, W.-X., Golden, L. R., Wilcock, D. M., Jicha, G. A., et al. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.11.013 · Cited by 17
ApoE: The Non-Protagonist Actor in Neurological Diseases
Grimaldi, L., Bovi, E., Formisano, R., & Sancesario, G. M. (2024) · Genes · doi:10.3390/genes15111397 · Cited by 18
Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer’s disease
Vanya, Kumari, S., Bagri, K., & Deshmukh, R. R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.10.050 · Cited by 18
APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer’s Disease and Cardiovascular Disease
Лю, Ч., Liu, J., Wang, Y., Xu, S.-F., & Yu, L.-M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05629-3 · Cited by 22
Endogenous Human Proteins Interfering with Amyloid Formation
Gharibyan, A. L., Jayaweera, S. W., Lehmann, M., Anan, I., & Olofsson, A. (2022) · Biomolecules · doi:10.3390/biom12030446 · Cited by 17

Authors: Weisgraber, K. H.
Affiliations: University of California, San Francisco (US)
Corresponding author: Weisgraber, K H
Venue: Journal of Lipid Research
Publisher: Elsevier BV
Published: 1990-08
Volume: 31
Issue: 8
Pages: 1503-1511
ISSN: 0022-2275 (ISSN-L)
DOI: 10.1016/s0022-2275(20)42621-5
OpenAlex: W2155559959
Cited by: 304
References: 26
Citations by year: 2026: 9 · 2025: 13 · 2024: 7 · 2023: 8 · 2022: 11 · 2021: 4 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 12 · 2016: 7 · 2015: 5 · 2014: 6 · 2013: 9 · 2012: 5
FWCI: 14.01
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 11035 d)
Locations: Journal of Lipid Research (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: apolipoprotein E, apolipoprotein E isoforms, APOE ε4, APOE3, APOE2, serum lipoproteins, high-density lipoprotein, VLDL, disulfide bonds, serum cholesterol, LDL receptor
MeSH terms: Apolipoproteins E, Arginine, Cysteine, Humans, Lipoproteins, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Apolipoprotein E3, Apolipoprotein E4, Apolipoprotein E2, Lipoproteins, IDL

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks